Rethinking psychopharmacotherapy: The role of treatment context and brain plasticity in antidepressant and antipsychotic interventions (Q26776255)

2

0 references

U Bingel

3

0 references

B K Doering

4

0 references

R Schwarting

5

0 references

M Wöhr

6

0 references

U Schweiger

Neuroscience & Biobehavioral Reviews

7

0 references

language of work or name

English

0 references

publication date

January 2016

0 references

published in

0 references

volume

60

0 references

page(s)

51-64

0 references

cites work

Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Exercise for depression

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Placebo response in studies of major depression: variable, substantial, and growing

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Active placebos versus antidepressants for depression

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Haloperidol versus placebo for schizophrenia

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Exercise for depression

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Antidepressants versus placebo for depression in primary care

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Maintenance treatment with antipsychotic drugs for schizophrenia

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Amitriptyline versus placebo for major depressive disorder

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

A meta-analysis of the magnitude of biased attention in depression.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Atypical neuroleptics stimulate neurogenesis in adult rat brain

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Early exposure to haloperidol or olanzapine induces long-term alterations of dendritic form

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

A neurocomputational account of catalepsy sensitization induced by D2 receptor blockade in rats: context dependency, extinction, and renewal

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Post-extinction fluoxetine treatment prevents stress-induced reemergence of extinguished fear

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Hippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatment

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated rats

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Nonpharmacological bases of drug tolerance and dependence.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The role of NMDA and AMPA/Kainate receptors in the consolidation of catalepsy sensitization

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The effects of isolated and enriched housing conditions on baseline and drug-induced behavioural responses in the male rat.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Long-term plasticity of visually evoked potentials in humans is altered in major depression

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effect of chronic antipsychotic treatment on brain structure: a serial magnetic resonance imaging study with ex vivo and postmortem confirmation.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Contrasting effects of haloperidol and lithium on rodent brain structure: a magnetic resonance imaging study with postmortem confirmation

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Treatment with olanzapine increases cell proliferation in the subventricular zone and prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Overgeneral autobiographical memory as a predictor of the course of depression: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Maximizing exposure therapy: an inhibitory learning approach

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effects of working memory training on functional connectivity and cerebral blood flow during rest

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Eye tracking of attention in the affective disorders: a meta-analytic review and synthesis

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Haloperidol modulates midbrain-prefrontal functional connectivity in the rat brain

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Schizophrenia, antipsychotics and risk of hip fracture: a population-based analysis

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Delayed BDNF alterations in the prefrontal cortex of rats exposed to prenatal stress: preventive effect of lurasidone treatment during adolescence.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Combination of fluoxetine and extinction treatments forms a unique synaptic protein profile that correlates with long-term fear reduction in adult mice

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Meta-analysis of the placebo response in antidepressant trials

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The prospective long-term course of adult depression in general practice and the community. A systematic literature review

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The neurogenesis hypothesis of affective and anxiety disorders: Are we mistaking the scaffolding for the building?

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Enhancement of cognitive function in models of brain disease through environmental enrichment and physical activity

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Inhibition of adult hippocampal neurogenesis disrupts contextual learning but spares spatial working memory, long-term conditional rule retention and spatial reversal.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Adult neurogenesis is reduced in the dorsal hippocampus of rats displaying learned helplessness behavior

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Exercise affects memory acquisition, anxiety-like symptoms and activity of membrane-bound enzyme in brain of rats fed with different dietary fats: impairments of trans fat.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effects of chronic exercise and treatment with the antipsychotic drug olanzapine on hippocampal volume in adult female rats

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The hidden effects of blinded, placebo-controlled randomized trials: an experimental investigation

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effects of sertraline on behavioral alterations caused by environmental enrichment and social isolation

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Physical exercise down-regulated locomotor side effects induced by haloperidol treatment in Wistar rats

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Antipsychotic-associated neuronal changes in the brain: toxic, therapeutic, or irrelevant to the long-term outcome of schizophrenia?

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Antidepressants differentially modify the extinction of an aversive memory task in female rats.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effect of early life housing manipulation on baseline and drug-induced behavioural responses on neurochemistry in the male rat.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effects of antipsychotic D2 antagonists on long-term potentiation in animals and implications for human studies

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Influence of enrichment on behavioral and neurogenic effects of antidepressants in Wistar rats submitted to repeated forced swim test

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

New perspectives on the neurodevelopmental effects of SSRIs

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Utilizing placebo mechanisms for dose reduction in pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Striatal enlargement in rats chronically treated with neuroleptic.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The scientific and ethical basis for placebo-controlled trials in depression and schizophrenia: an FDA perspective

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Placebo eff ects in psychiatry: mediators and moderators

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Haloperidol conditioned catalepsy in rats: a possible role for D1-like receptors

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Amygdala-frontal couplings characterizing SSRI and placebo response in social anxiety disorder

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Moving from efficacy to effectiveness in cognitive behavioral therapy for psychosis: a randomized clinical practice trial

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Plasticity in gray and white: neuroimaging changes in brain structure during learning

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Neural mechanisms of social risk for psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Mind matters: placebo enhances reward learning in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Reduced stress-sensitivity or increased reward experience: the psychological mechanism of response to antidepressant medication.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Neuroplasticity in depressed individuals compared with healthy controls

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Facilitation of serotonin signaling by SSRIs is attenuated by social isolation.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The placebo response in medicine: minimize, maximize or personalize?

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

1 reference

7 January 2021

Critical period plasticity in local cortical circuits

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The contextual brain: implications for fear conditioning, extinction and psychopathology

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Expectation in perceptual decision making: neural and computational mechanisms

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

BDNF in schizophrenia, depression and corresponding animal models

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effects of chronic haloperidol and clozapine treatment on neurogenesis in the adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Reversal of hippocampal neuronal maturation by serotonergic antidepressants.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Stress coping stimulates hippocampal neurogenesis in adult monkeys

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Prenatal exposure to antidepressants and depressed maternal mood alter trajectory of infant speech perception

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Physical exercise-induced hippocampal neurogenesis and antidepressant effects are mediated by the adipocyte hormone adiponectin

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Catalepsy intensifies context-dependently irrespective of whether it is induced by intermittent or chronic dopamine deficiency

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Context-dependent catalepsy intensification is due to classical conditioning and sensitization

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Effect of environmental cues on the behavioral efficacy of haloperidol, olanzapine, and clozapine in rats

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Contextual and behavioral control of antipsychotic sensitization induced by haloperidol and olanzapine

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Modeling social influences on human health

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Expectancies as core features of mental disorders

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Plasticity of ocular dominance columns in monkey striate cortex

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

A follow-up fMRI study of a transferable placebo anxiolytic effect.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Prenatal antidepressant exposure: clinical and preclinical findings

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The antidepressant fluoxetine restores plasticity in the adult visual cortex

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Perineuronal nets protect fear memories from erasure

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Induction of fear extinction with hippocampal-infralimbic BDNF

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Fear erasure in mice requires synergy between antidepressant drugs and extinction training.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Synaptic dysfunction in depression: potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Drug approval and drug effectiveness

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Emotion circuits in the brain

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Adult neurogenesis: beyond learning and memory

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Adult neuroplasticity: more than 40 years of research

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Chronic fluoxetine treatment suppresses plasticity (long-term potentiation) in the mature rodent primary auditory cortex in vivo

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Catatonic behavior induced by haloperidol, increased by retesting and elicited without drug in rats

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Changes in brain function of depressed subjects during treatment with placebo

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The functional neuroanatomy of the placebo effect

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Linking Molecules to Mood: New Insight Into the Biology of Depression

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Combined Prolonged Exposure Therapy and Paroxetine for PTSD Related to the World Trade Center Attack: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

A model of placebo response in antidepressant clinical trials

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

A novel application of the Intent to Attend assessment to reduce bias due to missing data in a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Twenty-five year mortality of a community cohort with schizophrenia

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Assessment of adverse effects in clinical studies of antipsychotic medication: survey of methods used.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Environmental enrichment induces behavioral recovery and enhanced hippocampal cell proliferation in an antidepressant-resistant animal model for PTSD.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Physical skill training increases the number of surviving new cells in the adult hippocampus

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Desvenlafaxine may accelerate neuronal maturation in the dentate gyri of adult male rats

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Neurobiological mechanisms of the placebo effect.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Glucocorticoids orchestrate divergent effects on mood through adult neurogenesis.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Fluoxetine exposure during adolescence alters responses to aversive stimuli in adulthood

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

The placebo response in pain and depression: in search of a common pathway

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021

Long-term antidepressant use and the risk of type 2 diabetes mellitus: a population-based, nested case-control study in Taiwan

1 reference

https://api.crossref.org/works/10.1016/J.NEUBIOREV.2015.11.008

7 January 2021